Abstract: This novel therapeutic (reparative, etiotropic not merely symptomatolytic) electrostimulatory method hereinafter referred to as Coupled Neuraxial Mesoscopic Desynchronization Electrostimulation Therapy (cNMDET) is comprised of a varied combination of progressively sequenced electrode placements and its clinically targeted areas which are comprised of the CNS [regions of the brain and spinal cord including, but not limited to, the underlying clinicopathologic mechanisms of the ANS] and clinically involved components of the PNS variably coupled in such a manner as to apply this therapeutic electrostimulation (reparative modulation) along the coursing path (longitudinally) of the targeted neural pathway over a segment and/or in its entirety, as well as, the utilization of patterned applications for involved joints, muscles, fascia, ligaments, tendons and areas involved in inflammatory processes of clinical significance accomplished through the application of, preferably, but not limited to, Coupled Neuraxial Tra

Abstract: A central pain management system (Algotron) comprising the relationships involving the use of a pain treatment system (Remote Algotron), novel pain treatment device (Neuraxial Transcutaneous Electrical Nerve Stimulator NTENS), Central Computer, Clinical Resource comprising a clinical-outcomes knowledgebase (AlgoNeuroMatrix), a Clinical Triage Resource, Protocol Generator and Stimulation Pattern Generator, the Algotron also includes combinations of network architectures to coordinate between a patient, Licensee/Provider, Licensee/Provider Computer, internet and real-time data point streaming are disclosed.